Tenant News
Global role for drug discovery enterprise
A business that grew out of research laboratories at Norwich ’ s world-renowned John Innes Centre has become a global force in the battle against infectious diseases and cancer
Inspiralis supplies vital products and services to businesses and academics working at the forefront of drug discovery and antibiotic development . It is one of a number of innovative new businesses that have prospered within the supportive environment of the Norwich Research Park .
Founded in 2008 to service the needs of professionals working in specialist areas of biochemistry , Inspiralis ’ customer base spans the globe – and it is widely recognised as the number one topoisomerase company in the world .
“ A key element of our business is to supply the necessary tools and materials to develop and screen novel antiinfective and anti-cancer compounds ,” said Founder Director Dr Nicolas Burton .
“ The overseas demand for our services from research groups working in the
Dr Sally Ann Forsyth , Chief Executive Officer Norwich Research Park with Inspiralis directors Alison Howells and Dr Nicolas Burton
pharmaceutical industry and academia around the world is so great that today 90 per cent of our products are exported .”
Inspiralis has continued to go from strength to strength , recently expanding into new premises at the Innovation Centre .
Dr Sally Ann Forsyth , Chief Executive Officer at Norwich Research Park said : “ Norwich Research Park provides a great environment for start-up science based businesses . The flexible accommodation and offer of shared equipment makes it the ideal location for companies , particularly at the early stages of their development when access to affordable scientific facilities and free business support is so important to their growth .”
34 SUMMER 2016